Skip to main content

Table 1 Demographics and baseline laboratory tests by treatment group.

From: Effects of 1,25-Dihydroxycholecalciferol on Recovery and Resolution of Late Transient Neonatal Hypocalcemia

(Units) BirthWeight(kg) Age (days) Gender (M/F) Ethnicity(Hispanic/Caucasian) Ionized Calcium (mmol/L) Phosphorus (mg/dL) Mg (mg/dl) Intact PTH (pg/mL) 25(OH) Vitamin D (ng/mL) 1,25(OH)2Vitamin D (pg/mL)
Placebo 4.06 ± 0.30 5.4 ± 0.5 6/1 6/1 0.86 ± 0.04 10.5 ± 0.3* 1.3 ± 0.1 26.0 ± 4.0 14.2 ± 2.8 159.4 ± 31.1
1,25(OH2)Vitamin D 3.73 ± 0.21 6.3 ± 0.4 6/1 4/3 0.88 ± 0.02 9.4 ± 0.2 1.2 ± 0.1 31.6 ± 4.7 15.1 ± 2.8 140.3 ± 10.7
Mean 3.91 ± 0.16 5.9 ± 0.3    0.87 ± 0.02 10.0 ± 0.2 1.2 ± 0.1 30.0 ± 3.0 15.0 ± 2.0 148.0 ± 14.0
Mother     HgA1C (%) 5.2 ± 0.4 Total Calcium(mg/dl) 9.35 ± 0.35 3.6 ± 0.2 3.0 ± 0.8 65.2 ± 16.3 15.3 ± 4.0 36.8 ± 5.0
  1. ; -test when compared to 1,25(OH)2 Vitamin D group Conversion factors:
  2. Phosphorus mmol/L = mg/dL 0.32.
  3. Magnesium mmol/L = mg/dL 0.5.